Search

everythinglearnresearchcommunity

for

Search:↓

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Cancer treatments targeting specific cells often cause skin problems, which can affect how much medicine patients can take.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

Certain immune cells may cause hair loss by reacting to stressed hair follicles.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Stem cell vesicles reduced eczema symptoms in mice safely.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

CK 19 expression is higher in more severe skin cancers.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.